Dr. Feldman on Managing Patients With Prostate Cancer Under Active Surveillance

Published: Tuesday, Aug 08, 2017



Adam Scott Feldman, MD, MPH, urologist at Massachusetts General Hospital, assistant professor of surgery, Harvard Medical School, discusses managing patients with prostate cancer under active surveillance.

Active surveillance is a positive option for many men with prostate cancer, as systemic treatment and radiation therapy have significant side effects.

When physicians are approaching the option of active surveillance with a patient, they must first help their patient cope with the diagnosis and then give necessary counseling, says Feldman.
 


Adam Scott Feldman, MD, MPH, urologist at Massachusetts General Hospital, assistant professor of surgery, Harvard Medical School, discusses managing patients with prostate cancer under active surveillance.

Active surveillance is a positive option for many men with prostate cancer, as systemic treatment and radiation therapy have significant side effects.

When physicians are approaching the option of active surveillance with a patient, they must first help their patient cope with the diagnosis and then give necessary counseling, says Feldman.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x